XNK Therapeutics is a clinical stage, immunotherapy company.
XNK Therapeutics has raised $156K in total funding. The most recent round was Grant. The last funding was announced in October 2023.
XNK Therapeutics's investors include Vinnova, Flerie Invest, Business Sweden's Catalyst.
XNK Therapeutics is headquartered in Huddinge, Sweden.
XNK Therapeutics is a clinical stage, immunotherapy company.
XNK Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"XNK Therapeutics — Funding & Investors." VCBacked, October 10, 2023, https://www.vcbacked.co/company/xnk-therapeutics. Accessed November 15, 2026.
VCBacked. (2023). XNK Therapeutics — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/xnk-therapeutics
{{cite web |title=XNK Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/xnk-therapeutics |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at XNK Therapeutics? Request a listing update